ScinoPharm announces investment with Tanvex Biologics

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Sep 2 2010ScinoPharm Taiwan, Ltd.

ScinoPharm, a leading active pharmaceutical ingredient (API) developer and manufacturer headquartered in Taiwan, today announced an investment into Tanvex Biologics, Inc., a United States company registered in the State of Delaware. ScinoPharm's investment was in the form of tangible assets, intellectual properties, as well as cash.

Tanvex specializes in the development of biosimilars and biobetters, as well as the provision of contract research and contract manufacturing services for biologics. The company is currently establishing a cGMP facility in San Diego, California and will have research centers in both the U.S. and Taiwan. Tanvex is founded by Dr. Allen Chao, the founder and former Chairman and Chief Executive Officer of Watson Pharmaceuticals, Inc.

Dr. Hardy Chan, co-founder and Chief Scientific Officer of ScinoPharm, will become the Chief Executive Officer of Tanvex. Dr. Chao will remain as Executive Chairman of Tanvex.

Source:

ScinoPharm Taiwan, Ltd.

Posted in:

Tags: , , ,

Comments (0)

Suggested Reading

Rising antibiotic resistance prompts shift to ecological research strategies in infection control
Research reveals decline in childhood mortality extended US women's lifespan by a year
Expanding research and clinical options for children with cancer
New research pinpoints key pathways in prostate cancer's vulnerability to ferroptosis
What is the ‘immune self,’ and how can this concept benefit immunological research?
Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses
Research validates anti-inflammatory properties of wine using urinary tartaric acid as biomarker

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Research explores the health benefits of resistant starch in plant-based diets